Review
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2005; 11(20): 3011-3013
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3011
Research progress on Helicobacter pylori outer membrane protein
Shi-He Shao, Hua Wang, Shun-Gen Chai, Li-Mei Liu
Shi-He Shao, Shun-Gen Chai, Department of Medical Microbiology and Parasitology, Medical Technology College, Jiangsu University, Zhenjiang 212001, Jiangsu Province, China
Hua Wang, Li-Mei Liu, Graduate Student, Medical College, Northern University, Jilin 132001, Jilin Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Research Plan of Jiangsu Provincial Technology Commission, No. BS2004021; Advanced Talent Research Plan of Jiangsu University, No. JDG2004008
Correspondence to: Shi-He Shao, Department of Medical Microbiology and Parasitology, Medical Technology College, Jiangsu University, Zhenjiang 212001, Jiangsu Province, China. ljxwl123@163.com
Telephone: +86-511-2165735
Received: November 8, 2004
Revised: November 9, 2004
Accepted: December 3, 2004
Published online: May 28, 2005

Abstract

Helicobacter pylori (H pylori), one of the most common bacterial pathogens on human beings, colonizes the gastric mucosa. In its 95 paralogous gene families, there is a large outer membrane protein (OMP) family. It includes 32 members. These OMP are important for the diagnosis, protective immunity, pathogenicity of H pylori and so on. They are significantly associated with high H pylori density, the damage of gastric mucosa, high mucosal IL-8 levels and severe neutrophil infiltration. We introduce their research progress on pathogenicity.

Key Words: H pylori, Outer membrane protein, oipA, Gastric carcinoma



INTRODUCTION

Helicobacter pylori (H pylori) is a noninvasive bacterium. Since Warran and Marshell isolated H pylori successfully in 1983, it has been identified as the major causative factor of chronic gastric and peptic ulcer disease and closely related to the occurrence and development of gastric carcinoma, mucosa-associated lymphoid tissue (MALT) lymphoma. In 1994 international cancer institute had determined it being type I carcinogen[1]. Studies regarding the H pylori virulence have primarily focused on urease, vacuolating cytotoxin, and cytotoxin-associated antigen. However, in its 95 paralogous gene families there is a large H pylori outer membrane protein (Hop) family. It includes 32 members[2,3], such as adhesin protein, proinflammatory protein, and micropore protein. Although some functions of these OMP have still been indefinite, the scholars at home and abroad have paid attention to them on diagnosis, protective immunity, pathogenicity and so on. The documents show that Hop is significantly associated with high H pylori colonization, the damage of gastric mucosa, high mucosal IL-8 levels, and neutrophil infiltration. We will review these aspects of OMP.

OMP AND CHRONIC GASTRITIS AND PEPTIC ULCERS
Adhesin protein

We have known that adherence to the epithelium is an important premise that bacteria settle down in the body. Adherence is believed to help protect the bacteria from gastric acidity, as well as from displacement due to peristalsis. HopZ, babA, and babB (blood-group antigen-binding gene), alpAB (adherence-associated lipoprotein) in the OMP are mainly related to adherence.

HopZ (HP9) is a vital adhesin protein. HopZ is primarily located in the bacterial surface, the number of its amino acids largely vary, ranging from 126 to 281. This is primarily because that HopZ gene suffers length-short regulation of different CT dinucleotide repetitive motif of different strains in the translational level. Birgit Peck[4] discovered that the wild-type strain ATCC43504 (HopZ negative) adhered to human gastric epithelial cells whereas a knockout mutant strain showed significantly reduced binding to the cells. Yamaoka[5] concluded: HopZ was significantly related to H pylori density and colonization ability in the mouse model.

babA (HP1234) and babB (HP0896) are OMP of having vital relation with adherence. Because their production binds LewisB antigen of human gastric cells, so are called blood-group-antigen-binding gene. Moreover the activity that the product of babA2 (allele of babA) binds LewisB antigen is higher[6]. But because people discovered H pylori expresses LewisB antigen, too. Therefore, some scholars doubt whether gastric epithelial cell-LewisB is the receptor of H pylori[7]. Ai-Fu Tang in China[8] persistently researched and testified that LewisB antigen expressed by H pylori did not affect H pylori adherence to LewisB and summit to secretion of host (secretory people have LewisB antigen in humoral fluid). But the author thought that the babA2 gene was not related to peptic ulcer, the same type of LewisB antigen expressed by H pylori as their host had the advantage of evading host immune system to survive, then triggered disease. Furthermore, host may trigger disease through producing autoantibody aiming at LewisB antigen. The research by Zambon[9] showed that babA2 and CagA-s1 and m1(allele of Vac) in H pylori acted together, which could obviously worsen the degree of inflammation.

AlpAB is also concerned with adhesion of H pylori. At present, it is being ascertained that AlpAB are two kinds of channel-forming membrane pore: hopB and hopC, which are organized in an operon[10]. Through designing the mutant strain AlpA or AlpB, Odenbreit testified AlpAB-specific adherence and concluded that the adherence was independent of the composition of the lipopolysaccharide (LPS)[11].

Proinflammatory

oipA (outer inflammatory protein, oipA), encoding OMP gene of relative molecular mass (Mr) of 34 ku, is called HopH (HP0638). The product is called proinflammatory. As early as 1998, Yamaoka[12] discovered that Mr ranging 33 ku to 35 ku OMP were positively correlated with the level of IL-8. However, there was no relationship between other antigens including CagA and production of IL-8. The 33-35 ku antigen was present in 97.5% patients with gastric or duodenal ulcer compared to 70% those with chronic gastritis. In order to ascertain the genic position of the protein, in 2000, Yamoka[13] designed the knockout mutant strain HP0638(Mr34 ku), HP0796(Mr33 ku), HP1501(Mr32 ku), compared with wild-type about inducing to secrete the level of IL-8. The result showed HP0796 and HP1501 had no significant effect on IL-8 product. However, knockout of the HP0638 gene reduced IL-8 product approximately 50%. Cag-negative strains that contained a functional HP0638 gene produced more than three-fold greater IL-8 than Cag-negative nonfunctional HP0638 strains. So the author denoted HP0638 gene as outer inflammatory protein (oipA). The recent data[14] showed that HP0638 frame status was correlated strongly with CagA, vacA iceA genotypes. All of the strains in which HP0638 was in frame were CagA positive and vacAs1, whereas most of the strains in which HP0638 was out of frame were CagA negative (80%) and vacAs2 (70%). So the author thought it suggested that CagA positivity could affect transcription of HP0638. But Yamaoka[15] discovered in his further research that oipA status remained in the final model to discriminate duodenal ulcer from gastritis. Functional oipA was significantly associated with high H pylori density, severe neutrophil infiltration and high mucosal IL-8 levels and further research that polyclonal antisera to either a synthetic oipA peptide or a recombinant oipA protein detected oipA expression in H pylori and correlated with functional oipA status determined by PCR sequence[16]. Moreover, the recent research showed that the detecting of oipA+HP was 46.6%. But oipA was detected in patients with gastric ulcer and the rate was 100%, which was obviously higher than in patients with gastritis. Thus, it indicated that oipA was significantly more frequent in patients with gastric ulcer[17].

OMP AND GASTRIC CARCINOMAS

Before discovering H pylori, people believed that gastric carcinomas evolved from superficial gastritis to chronic atrophic gastritis, then intestinal metaplasia and turned into gland cancer[18]. Hop played an important role in the process. Zambon[9] research testified that coexpressed by the same H pylori strain, CagA, s1 and m1Vac worded synergistically, not only were worsening inflammation, but also were at higher risk for intestinal metaplasia. The scholars in Taiwan[19] discovered that a significant association was found between the serum antibodies against lower-molecular-weight proteins of H pylori, especially 19.5 ku and 26.5 ku, and malignant outcome of H pylori infection. Wei-Hong Yang[20] discovered that antibody titre of 26.5 ku protein in gastritis group was higher than that in ulcer group, in moderate, severe inflammatory gastritis was higher than that in subinflammatory gastritis. These have the advantage of the occurrence and development of tumor. Therefore some scholars believe lower-molecular-weight OMP may act as gastric carcinomas and its hypercrowd screening , it is a kind of marking antigen[21,22].

OMP AND IMMUNITY
Cytokine

When infected by H pylori, inflammatory cytokine induced by OMP plays an important role in H pylori pathopoiesis. It has been definite that oipA is positively correlated with product of IL-8 as former statement[12]. Petra[23]discovered that HpaA and OMP18(Mr18000) induced IL-12 and IL-10 to secrete when researching their antigenicity . IL-8 is an main inflammatory promoter and regulatory factor. IL-12 was obviously positively correlated with the degree of T lymphoid infiltration in the mucous membrane and worsen gastric mucous inflammation[24].

Vaccinal research

Most OMP locates the surface of bacterial body, surface exposing, conserving relatively, inducing humoral immunity and so on. Thus, since early, people have begun researching its protective immunogenicity, but can get partial effect on protecting immunity[25,26]. Nowadays, many scholars have researched polyvalent vaccine. Zheng Jiang succeeded in constructing divalent vaccine of HpaA,OMP18 (Mr18000) and HpaA, OMP26 (26000), which laid the foundation of constructing H pylori protein vaccine[27,28].

CONCLUSIONS AND PERSPECTIVES

There are other OMP which deserve to be further studied. For example, Ping Cao[29]through researching two HopQ alleles discovered that type I HopQ alleles were found significantly more commonly in cag+/s1-vacA strains from patients with peptic ulcer disease than in cag-/s2-vacA strains from patients without ulcer disease. But Akihiro[30]through researching OMP29 (Mr29000) from being isolated ATCC43504 strains discovered that OMP29 could alter its antigenicity through gene modifications mediated by nucleotide transfer. These discovers are looking forward to further probing and studying. At present, genome sequence of H pylori OMP have finished, but the function of many OMP has been indefinite: how on earth they induce to disease, the relation with other virulence factor: Cag pathogenicity island and VacA, which antigenicity is more. These are still not clear. However, there are many questions in former research, for example , Yamaoka thought oipA frame status was an unique index that discriminated duodenal from gastritis. But the author didn’t examine gene of encoding 35 ku protein. Wei-Hong Yang[20] in China did the correlation research and discovered that in quantitative study ,the antibody titre of 35 ku protein in original duodenal bulb ulcer group was obviously higher than that in chronic superficial gastritis group.

In a word, researching virulence and pathogenicity of H pylori is a vital significance. This can discover new strains and further illuminate pathogenic mechanism, on the other hand, can provide basis for vaccinal screening, designing and immunity strategy. This can avail the development of a new particularity diagnosis reagent kit.

Footnotes

Science Editor Guo SY Language Editor Elsevier HK

References
1.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994;272:65-69.  [PubMed]  [DOI]
2.  Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388:539-547.  [PubMed]  [DOI]
3.  Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun. 2000;68:4155-4168.  [PubMed]  [DOI]
4.  Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res. 1999;27:3325-3333.  [PubMed]  [DOI]
5.  Yamaoka Y, Kita M, Kodama T, Imamura S, Ohno T, Sawai N, Ishimaru A, Imanishi J, Graham DY. Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology. 2002;123:1992-2004.  [PubMed]  [DOI]
6.  Pride DT, Meinersmann RJ, Blaser MJ. Allelic Variation within Helicobacter pylori babA and babB. Infect Immun. 2001;69:1160-1171.  [PubMed]  [DOI]
7.  Clyne M, Drumm B. Absence of effect of LewisA and LewisB expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology. 1997;113:72-80.  [PubMed]  [DOI]
8.  Tang FA, Zheng PY, Li ZF, Feng CW, Hua JS, Duan CL. No influence of Lewis B expression in Helicobacter pylori on bacterial adhesion property. Zhonghua Xiaohua Zazhi. 2001;21:162-164.  [PubMed]  [DOI]
9.  Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003;56:287-291.  [PubMed]  [DOI]
10.  Odenbreit S, Till M, Hofreuter D, Faller G, Haas R. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol Microbiol. 1999;31:1537-1548.  [PubMed]  [DOI]
11.  Odenbreit S, Faller G, Haas R. Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int J Med Microbiol. 2002;292:247-256.  [PubMed]  [DOI]
12.  Yamaoka Y, Kodama T, Graham DY, Kashima K. Search for putative virulence factors of Helicobacter pylori: the low-molecular-weight (33-35 K) antigen. Dig Dis Sci. 1998;43:1482-1487.  [PubMed]  [DOI]
13.  Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA. 2000;97:7533-7538.  [PubMed]  [DOI]
14.  Ando T, Peek RM, Pride D, Levine SM, Takata T, Lee YC, Kusugami K, van der Ende A, Kuipers EJ, Kusters JG. Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J Clin Microbiol. 2002;40:239-246.  [PubMed]  [DOI]
15.  Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002;123:414-424.  [PubMed]  [DOI]
16.  Kudo T, Nurgalieva ZZ, Conner ME, Crawford S, Odenbreit S, Haas R, Graham DY, Yamaoka Y. Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol. 2004;42:2279-2281.  [PubMed]  [DOI]
17.  Zhang J, Yu FF, Chen YX, Chen H. Detection of cagA, oipA and iceAl genes of Helicobacter pylori and its significance. Zhongguo Weisheng Jianyan Zazhi. 2004;14:133-134.  [PubMed]  [DOI]
18.  Guchuan CY. Helicobacter pylori infection and gastric carcinomas. J Med Introduction. 2003;24:217-218.  [PubMed]  [DOI]
19.  Shiesh SC, Sheu BS, Yang HB, Tsao HJ, Lin XZ. Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan. Dig Dis Sci. 2000;45:781-788.  [PubMed]  [DOI]
20.  Yang WH, Lin SR, Wang LX, Ding SG, Jin Z. The relationship between the pathogenetic factors of Helicobacter pylori and gastric diseases. J Beijing Med University. 2000;32:34-38.  [PubMed]  [DOI]
21.  Jiang Z, Huang AL, Wang ZQ, Tao XH, Wang PL, Pu D. Cloning and expression of 18000 u outer membrane proteh gene of Helicobacter pylori. Shijie Huaren Xiaohua Zazhi. 2002;10:266-270.  [PubMed]  [DOI]
22.  Jiang Z, Huang AL, Wang PL, Tao XH, Pu D. The cloning and recombinant vector constructing of lower-weight outer membrane protein encoding gene of Helicobacter pylori. Shijie Huaren Xiaohua Zazhi. 2001;9:1316-1318.  [PubMed]  [DOI]
23.  Voland P, Hafsi N, Zeitner M, Laforsch S, Wagner H, Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect Immun. 2003;71:3837-3843.  [PubMed]  [DOI]
24.  Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol. 1999;117:316-323.  [PubMed]  [DOI]
25.  Chen J, Chen WH, Zhu SL, Chen W. Immunization against Helicobacter pylori infection with Helicobacter pylori outer membrane protein vaccine. Weichangbingxue. 2001;6:75-76.  [PubMed]  [DOI]
26.  Lin HJ, Wang JD, Bai Y, Zhang YL, Zhou DY. The in vivo and in vitro evaluation of the immune protective activity of the recombinant surface proteins of Helicobacter pylori. Zhongguo Weishengtai Zazhi. 2003;15:4-6.  [PubMed]  [DOI]
27.  Jiang Z, Huang AL, Tao XH, Wang PL. Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori. World J Gastroenterol. 2003;9:1756-1761.  [PubMed]  [DOI]
28.  Jiang Z, Pu D, Huang AL, Tao XH, Wang PL. Construction, expression and antigenic study of bivalent vaccine candidate with 26,000 OMP and heat short protein A of human Helicobacter pylori. Zhonghua YiXue ZaZhi. 2003;83:862-867.  [PubMed]  [DOI]
29.  Cao P, Cover TL. Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol. 2002;40:4504-4511.  [PubMed]  [DOI]
30.  Sumie A, Yamashiro T, Nakashima K, Nasu M, Watanabe M, Nishizono A. Comparison of genomic structures and antigenic reactivities of orthologous 29-kilodalton outer membrane proteins of Helicobacter pylori. Infect Immun. 2001;69:6846-6852.  [PubMed]  [DOI]